Ecust004 Suppresses Breast Cancer Cell Growth, Invasion, and Migration via EMT Regulation
Ziyu Liu,1,2 Leilei Huang,3,4 Liwei Sun,1 Hui Nie,3,4 Yuqi Liang,1,2 Jinwen Huang,3,4 Fanhong Wu,3,4 Xin Hu1 1The Laboratory of Cancer Biology, China-Japan Union Hospital of Jilin University, Jilin University, Changchun, Jilin, People’s Republic of China; 2Department of Biochemistry and Molecular Bi...
Main Authors: | Liu Z, Huang L, Sun L, Nie H, Liang Y, Huang J, Wu F, Hu X |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-08-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/ecust004-suppresses-breast-cancer-cell-growth-invasion-and-migration-v-peer-reviewed-fulltext-article-DDDT |
Similar Items
-
Development of erianin-loaded dendritic mesoporous silica nanospheres with pro-apoptotic effects and enhanced topical delivery
by: Canlong Mo, et al.
Published: (2020-03-01) -
Research advances of erianin: Source, production, biological activities and pharmacological properties
by: Qinghe Qiao, et al.
Published: (2022-03-01) -
Radiosynthesis and Tumor MicroPET/CT Imaging of 18F-Fluoroethoxylerianin, an 18F-Labeled Erianin Analogue
by: Hui Nie, et al.
Published: (2022-04-01) -
An In Vitro Approach to Model EMT in Breast Cancer
by: Lorenz Isert, et al.
Published: (2023-04-01) -
An EGFR‐targeting antibody–drug conjugate LR004‐VC‐MMAE: potential in esophageal squamous cell carcinoma and other malignancies
by: Xin‐yue Hu, et al.
Published: (2019-02-01)